SBIR/STTR Research Award
GENE DIVERSIFICATION BY DIRECTED RETROTRANSPOSITION
Award amount
$100,000Program and phase
SBIR · Phase IAward year
2002Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- NEUGENESIS CORPORATION
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): Gene-products of recombinant origin have
substantial commercial value for pharmaceutical and technical uses. Directed
evolution approaches to generate new or improved products have successfully
been applied in instances where structure-function data for target molecules
are limited. Current approaches use in vitro techniques to generate diversity.
These methods have a number of shortcomings due to expense and difficulty in
creation of large molecular diversity libraries containing new variants. The
use of a concerted in vivo process that generates large libraries of cells
producing variants of the starting molecule, would result in considerable cost
and effort savings. The fungus Neurospora crassa has the ability to correctly
express, fold, modify and secrete active eukaryotic proteins, and the ability
to "shuffle" DNA sequences in vivo by high-frequency meiotic gene conversion.
The addition of a method to induce targeted mutations into an expressed
heterologous gene would allow rapid screening of new variants, with no
additional molecular manipulations. This proposal investigates the potential to
use directed retrotransposition to introduce mutation into heterologous
sequences in this fungus. Experiments to demonstrate controlled transduction of
transposon-reporter chimeras between genetically marked nuclei will be
performed. The long term outcome of this proposal is to generate molecular
diversity in target genes, for screening of new activities and products.
PROPOSED COMMERCIAL APPLICATION:
This proposal tests a new method for in vivo diversification of genes by retrotransposition.
This error-prone process may then be used to generate simple and robust molecular
diversity libraries for screening of new variants of commercially valuable gene-products. Success will lead to a novel alternative method for directed evolution of new or improved products, allowing entry into markets for new pharmaceutical, industrial and agricultural products.
Technology keywords
Not reported